Response to: Bioactive Lipids and Coronavirus (COVID-19)-further Discussion.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

17 citing papers in PubMed.

1. Can essential fatty acids (EFAs) prevent and ameliorate post-COVID-19 long haul manifestations?Lipids in health and disease · 2024
   Review
2. Research Advances on the Role of Lipids in the Life Cycle of Human Coronaviruses.Microorganisms · 2023
   Review
3. Bioactive lipid-based therapeutic approach to COVID-19 and other similar infections.Archives of medical science : AMS · 2023
   Article
4. Evaluation of erythrocyte membrane fatty-acid compositions in association with interleukin-6 levels in patients with COVID-19.Nutrition (Burbank, Los Angeles County, Calif.) · 2022
   Article
5. Effectiveness of Borage plus syrup on COVID-19 patients in intensive care units.Frontiers in nutrition · 2022
   Article
6. ELV-N32 and RvD6 isomer decrease pro-inflammatory cytokines, senescence programming, ACE2 and SARS-CoV-2-spike protein RBD binding in injured cornea.Scientific reports · 2021
   Article
7. Dissecting lipid metabolism alterations in SARS-CoV-2.Progress in lipid research · 2021
   Review
8. Can N-3 polyunsaturated fatty acids be considered a potential adjuvant therapy for COVID-19-associated cardiovascular complications?Pharmacology & therapeutics · 2021
   Review
9. "Cell Membrane Theory of Senescence" and the Role of Bioactive Lipids in Aging, and Aging Associated Diseases and Their Therapeutic Implications.Biomolecules · 2021
   Review
10. Essential fatty acids and their metabolites in the pathobiology of (coronavirus disease 2019) COVID-19.Nutrition (Burbank, Los Angeles County, Calif.) · 2021
    Article
11. Coronavirus-Induced Host Cubic Membranes and Lipid-Related Antiviral Therapies: A Focus on Bioactive Plasmalogens.Frontiers in cell and developmental biology · 2021
    Review
12. Bioactive Lipids in COVID-19-Further Evidence.Archives of medical research · 2021
    Review
13. Food Ingredients and Active Compounds against the Coronavirus Disease (COVID-19) Pandemic: A Comprehensive Review.Foods (Basel, Switzerland) · 2020
    Review
14. Targeting hypertriglyceridemia to mitigate cardiovascular risk: A review.American journal of preventive cardiology · 2020
    Review
15. Can Bioactive Lipid Arachidonic Acid Prevent and Ameliorate COVID-19?Medicina (Kaunas, Lithuania) · 2020
    Article
16. SARS-CoV-2 Infection and Lung Cancer: Potential Therapeutic Modalities.Cancers · 2020
    Review
17. Bioactive Lipids as Mediators of the Beneficial Action(s) of Mesenchymal Stem Cells in COVID-19.Aging and disease · 2020
    Article

Corrections and comments

• Comment on
  Bioactive Lipids and Coronavirus.2020

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.